These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12622553)

  • 41. Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysis.
    Guerra EN; Rêgo DF; Elias ST; Coletta RD; Mezzomo LA; Gozal D; De Luca Canto G
    Crit Rev Oncol Hematol; 2016 May; 101():93-118. PubMed ID: 26971993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effective head and neck tumor markers. The continuing quest.
    Ropka ME; Goodwin WJ; Levine PA; Sasaki CT; Kirchner JC; Cantrell RW
    Arch Otolaryngol Head Neck Surg; 1991 Sep; 117(9):1011-4. PubMed ID: 1910716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cutaneous melanocytic tumors. Case 7].
    de la Fouchardière A
    Ann Pathol; 2016 Oct; 36(5):341-344. PubMed ID: 27639772
    [No Abstract]   [Full Text] [Related]  

  • 44. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Report of the National Oncology Research and Developement Consortium, 2003].
    Tímár J
    Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumour-derived plasma cell-free DNA in patients with head and neck cancer: A short review.
    Rave-Fränk M
    Cancer Radiother; 2017 Oct; 21(6-7):554-556. PubMed ID: 28847459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective Biomarkers and Radiation Treatment in Head and Neck Cancer.
    Ow TJ; Pitts CE; Kabarriti R; Garg MK
    Arch Pathol Lab Med; 2015 Nov; 139(11):1379-88. PubMed ID: 26046489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small RNAs are raising big expectations.
    Hede K
    J Natl Cancer Inst; 2009 Jun; 101(12):840-1. PubMed ID: 19509361
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
    Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
    Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.
    Brauswetter D; Dános K; Gurbi B; Félegyházi ÉF; Birtalan E; Meggyesházi N; Krenács T; Tamás L; Peták I
    Virchows Arch; 2016 May; 468(5):579-87. PubMed ID: 26832731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
    Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
    Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients.
    Chang JT; Wong FH; Liao CT; Chen IH; Wang HM; Cheng AJ
    Clin Chem; 2004 Jul; 50(7):1261-4. PubMed ID: 15229162
    [No Abstract]   [Full Text] [Related]  

  • 53. Molecular profiling of head and neck squamous cell carcinoma.
    Feldman R; Gatalica Z; Knezetic J; Reddy S; Nathan CA; Javadi N; Teknos T
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1625-38. PubMed ID: 26614708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers of squamous cell carcinoma of the head and neck.
    Kim J; Shin DM
    Histol Histopathol; 1997 Jan; 12(1):205-18. PubMed ID: 9046056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MDM2 and TP53 Polymorphisms as Predictive Markers for Head and Neck Cancer in Northeast Indian Population: Effect of Gene-Gene and Gene-Environment Interactions.
    Bhowmik A; Das S; Bhattacharjee A; Choudhury B; Naiding M; Deka S; Ghosh SK; Choudhury Y
    Asian Pac J Cancer Prev; 2015; 16(14):5767-72. PubMed ID: 26320449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer.
    Keam B; Kim HR; Yun HJ
    Cancer Res Treat; 2019 Jan; 51(1):413-414. PubMed ID: 30064199
    [No Abstract]   [Full Text] [Related]  

  • 57. Aurora sheds light on head and neck squamous cell carcinoma.
    Han H; Von Hoff DD
    Clin Cancer Res; 2006 Sep; 12(17):5003-4. PubMed ID: 16951211
    [No Abstract]   [Full Text] [Related]  

  • 58. [Genetic mutation in head and neck squamous cell carcinoma].
    Shiga K
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Oct; 105(10):1059-64. PubMed ID: 12549511
    [No Abstract]   [Full Text] [Related]  

  • 59. Chromosomal changes characterize head and neck cancer with poor prognosis.
    Bauer VL; Braselmann H; Henke M; Mattern D; Walch A; Unger K; Baudis M; Lassmann S; Huber R; Wienberg J; Werner M; Zitzelsberger HF
    J Mol Med (Berl); 2008 Dec; 86(12):1353-65. PubMed ID: 18810378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNAs and head and neck cancer: reviewing the first decade of research.
    Sethi N; Wright A; Wood H; Rabbitts P
    Eur J Cancer; 2014 Oct; 50(15):2619-35. PubMed ID: 25103455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.